SLC19A3 (NM_025243) Human Untagged Clone

CAT#: SC108121

SLC19A3 (untagged)-Human solute carrier family 19, member 3 (SLC19A3)



  "NM_025243" in other vectors (5)

CNY 3,656.00


货期*
现货

规格
    • 10 ug

Product images

经常一起买 (4)
TurboFectin Transfection Reagent (1 mL in 1 vial)
    • 1 ml in 1 vial

CNY 4,090.00


DH5α Chemically Competent Cells (≥10^8 cfu/μg of pUC19 DNA)
    • 5 x 200 ul

CNY 1,280.00


Forward sequencing primer VP1.5, Reverse sequencing primer XL39, 100pmoles each
    • 100 pmol

CNY 480.00


SLC19A3 Antibody - middle region
    • 100 ul

CNY 5,250.00

Specifications

Product Data
Type Human Untagged Clone
Tag Tag Free
Synonyms BBGD; THMD2; thTr-2; THTR2
Vector pCMV6-XL4
E. coli Selection Ampicillin (100 ug/mL)
Mammalian Cell Selection None
Sequence Data
>OriGene ORF within SC108121 sequence for NM_025243 edited (data generated by NextGen Sequencing)
ATGGATTGTTACAGAACTTCACTAAGCAGTTCCTGGATTTACCCCACTGTGATCCTCTGC
TTATTTGGTTTTTTCTCCATGATGAGACCCTCAGAACCATTCCTTATCCCATATTTATCT
GGACCAGATAAAAACCTGACCAGTGCAGAGATAACAAATGAGATCTTCCCCGTTTGGACA
TACTCCTACCTGGTGCTGCTGCTGCCTGTGTTTGTCCTCACCGATTATGTCCGCTACAAG
CCAGTCATCATCTTGCAAGGTATCAGTTTCATCATTACCTGGCTGCTGCTGTTGTTTGGC
CAAGGAGTGAAGACCATGCAGGTTGTAGAGTTCTTCTATGGGATGGTCACCGCCGCCGAG
GTGGCCTACTACGCCTACATATACAGCGTGGTCAGCCCCGAGCACTACCAGAGAGTGAGC
GGCTACTGCAGGAGCGTCACGCTGGCCGCCTACACAGCAGGGTCGGTGCTGGCTCAACTC
TTGGTATCCCTGGCGAACATGTCGTACTTTTACCTCAACGTCATATCCTTGGCCTCTGTC
TCCGTGGCTTTCCTTTTCTCACTTTTCCTACCAATGCCCAAGAAAAGCATGTTTTTTCAT
GCAAAACCCAGCAGAGAAATAAAGAAGTCATCAAGCGTGAATCCAGTATTAGAGGAAACT
CACGAAGGTGAAGCACCAGGCTGTGAAGAGCAGAAACCCACATCAGAAATACTCAGCACT
TCAGGGAAGCTGAATAAGGGCCAGCTGAACAGCCTGAAACCAAGCAATGTGACTGTGGAC
GTTTTTGTGCAGTGGTTCCAAGATTTGAAGGAGTGCTACTCCTCAAAACGTCTTTTCTAC
TGGTCTCTATGGTGGGCTTTCGCCACAGCAGGTTTTAACCAGGTTTTGAACTATGTTCAA
ATCCTGTGGGATTACAAGGCGCCATCCCAAGATTCTTCCATCTATAATGGGGCCGTAGAA
GCTATTGCAACCTTTGGAGGGGCTGTGGCTGCCTTTGCAGTGGGTTATGTGAAAGTCAAC
TGGGACCTTCTGGGAGAGCTGGCTCTGGTGGTCTTCTCAGTTGTCAATGCCGGTTCTTTA
TTTCTCATGCATTACACAGCCAATATCTGGGCGTGCTATGCTGGCTATTTGATATTCAAG
TCCAGCTATATGCTTCTTATAACCATAGCAGTATTTCAGATTGCAGTTAATCTGAATGTG
GAACGCTATGCCTTGGTATTTGGAATCAACACCTTTATTGCCTTGGTGATTCAGACCATC
ATGACTGTGATTGTAGTAGATCAGAGAGGGCTCAACTTGCCAGTCAGCATTCAGTTTTTA
GTTTATGGGAGCTATTTTGCAGTAATTGCTGGAATTTTCCTAATGAGAAGCATGTATATT
ACCTACTCAACCAAATCCCAGAAGGATGTACAGAGCCCTGCTCCAAGTGAGAATCCAGAT
GTGTCTCACCCAGAGGAAGAGAGTAATATCATCATGTCAACAAAACTCTAA

Clone variation with respect to NM_025243.3
>OriGene 5' read for NM_025243 unedited
NGGTTTCAGATTTTGTAACACGATCTCACTATAGGGCGGCCGCGAATTCGCACCAGGGCA
AGTGAGCGATTTGGTGAACAGACACTCCCTTCTGTAGCCATGGATTGTTACAGAACTTCA
CTAAGCAGTTCCTGGATTTACCCCACTGTGATCCTCTGCTTATTTGGTTTTTTCTCCATG
ATGAGACCCTCAGAACCATTCCTTATCCCATATTTATCTGGACCAGATAAAAACCTGACC
AGTGCAGAGATAACAAATGAGATCTTCCCCGTTTGGACATACTCCTACCTGGTGCTGCTG
CTGCCTGTGTTTGTCCTCACCGATTATGTCCGCTACAAGCCAGTCATCATCTTGCAAGGT
ATCAGTTTCATCATTACCTGGCTGCTGCTGTTGTTTGGCCAAGGAGTGAAGACCATGCAG
GTTGTAGAGTTCTTCTATGGGATGGTCACCGCCGCCGAGGTGGCCTACTACGCCTACATA
TACAGCGTGGTCAGCCCCGAGCACTACCAGAGAGTGAGCGGCTACTGCAGGAGCGTCACG
CTGGCCGCCTACACAGCAGGGTCGGTGCTGGCTCAACTCTTGGTATCCCTGGCGAACATG
TCGTACTTTTACCTCAACGTCATATCCTTGGCCTCTGTCTCCGTGGCTTTCCTTTTCTCA
CTTTTCCTACCAATGCCCAAGAAAAGCATGTTTTTTCATGCANAACCCAGCAGAGAAATA
AAGAAGTCATCAAGCGTGAATCCAGTATTAGAGGAAACTCACGAAGGTGAAGCACCAGGC
TGTGAAGAGCAGAAACCCACATCAGAATACTCAGCACTTCAGGGAAGCTNGATAAGGGCC
AGCTGAACAGCCTGAAACCAAGCATGTGACTGTGGACGTTTTGTGCAGTGGTCCAAGATT
TGAAGAGTGCTACTCTCAA
>OriGene 3' read for NM_025243 unedited
ATCGAGTTTTAAATTCTTTTTTTTTGTAAAAAAAGGGTTTAATTAGCTCACAGGCTATAT
AGGAAGCGTGGCAACATCTGCTTCTAGGGAGTCCTCAGGGAATTTTTACTCATGGCAGAA
GGCAAAGTGGGAGCAGGCATCTTCACGTGGCCAAAGCAGGAGAAAGAGAGAGTGGGGAGG
TGCTACACACTTTTAAACTACCAGATCTCACGATAACTCACTGTCATGAGACCAGCACTG
AGGGGACGGTGCCAAACCATTCATGAAGGCTTCACACCCATGATCCAGTCGCCTCCCAGC
CGGCCCCACCTCTAACATTGGGGATTACACTTCAACGTGAGATTTGGTGGGGACACAGAT
CCAAACCATATCAAAATCCAATTAAAAATTTTTTTGTTTGTTTTAGACACAGGGTCTTGC
TATATTGGCCAAGATGGTCTCATACCCCTACCCTCAAATTAACCTCTCACTTCAGCCTCC
CAAAATGCTGGGATTACAGGTGTGAGCCAAAGCTTTCCAGCCTGATATAAATCTTGACTC
AGCATTTCTTATTCTCACTGTCAGACTGCTCAATGCATCCCTTATTGAAGTTTCTTTGAA
GTTTTCGAAAACAGGTATGTTCAGATAATTTTCAGCAGAATTCATCANANAATGTTAAAC
ACTGCTTAAAATTTTACACATTTTATTTAGCACAATTGCTACCATTTAAAAATCANNGTG
TTTTGCCAGCATGGGGGGGGCTCACGCCCTGTTATCTCAGCTCTTTTGGGAGGGCCGAGG
CAGACAGATCACCTGAAGTCAGGAGTTTNTGAGACCAGNNCTGGCCAACATTGTGAAACC
CCATCTCACTAAATACAAATCGGGGGG
Restriction Sites ECoRI-NOT     
ACCN NM_025243
Insert Size 4000 bp
OTI Disclaimer Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
Product Components The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).
Reconstitution 1. Centrifuge at 5,000xg for 5min.
2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.
5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.
Reference Data
RefSeq NM_025243.2, NP_079519.1
RefSeq Size 3532 bp
RefSeq ORF 1491 bp
Locus ID 80704
UniProt ID Q9BZV2
Domains Folate_carrier
Protein Families Transmembrane
Gene Summary This gene encodes a ubiquitously expressed transmembrane thiamine transporter that lacks folate transport activity. Mutations in this gene cause biotin-responsive basal ganglia disease (BBGD); a recessive disorder manifested in childhood that progresses to chronic encephalopathy, dystonia, quadriparesis, and death if untreated. Patients with BBGD have bilateral necrosis in the head of the caudate nucleus and in the putamen. Administration of high doses of biotin in the early progression of the disorder eliminates pathological symptoms while delayed treatment results in residual paraparesis, mild cognitive disability, or dystonia. Administration of thiamine is ineffective in the treatment of this disorder. Experiments have failed to show that this protein can transport biotin. Mutations in this gene also cause a Wernicke's-like encephalopathy.[provided by RefSeq, Jan 2010]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

Customer Reviews 
Loading...